NextPharma Technologies has sold Bioserv Corp., its U.S. affiliate in San Diego, to KESA Partners, Inc. NextPharma plans to focus on its core specialty and conventional product and technology platform in Europe, as well as expand its sales and marketing presence in North America. Bioserv provides contract manufacturing and packaging services to the pharma/biopharma industry.   Al Hansen, managing partner at KESA Partners, said, “This is an exciting time for Bioserv. For almost 20 years, Bioserv ...